Discover the top 3 undervalued Pharmaceuticals stocks for Wednesday, February 05 based on AAII’s Stock Grades.

As with climate change, why are we so slow to recognise the existential threat that drug use poses to humanity?

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. To ...

Now think of your mouth as such a city, with the oral microbiome making up the citizenry. Composed of hundreds of bacteria, viruses, fungi and other species, the oral microbiome is not just a ...

After hours: January 31 at 5:25:03 PM EST Loading Chart for COLL ...

2025 will bring new and familiar challenges for the health care industry, and the American Hospital Association is ready to support hospitals and health systems across the nation. In the first ...

2024 — A research team has developed a new class of oral peptide therapeutic leads for treating chronic abdominal pain. This groundbreaking innovation offers a safe, non-opioid-based solution ...

Rexulti (brexpiprazole) has potential interactions with alcohol and other medications. For example, Rexulti can interact with other antipsychotics, such as risperidone (Risperdal). An interaction ...

To sign up for Becker's GI & Endoscopy E-Newsletter or any of our other E-Newsletters, click here. If you are experiencing difficulty receiving our newsletters, you ...